Bionano stock dips amid launch of Bionano Laboratories for optical genome mapping tests
Sep. 23, 2022 9:07 AM ETBionano Genomics, Inc. (BNGO)By: Ravikash, SA News Editor5 Comments
- Bionano Genomics (NASDAQ:BNGO) said it launched Bionano Laboratories, which combines the company's optical genome mapping (OGM) data services with clinical testing services previously offered by Lineagen.
- The company also launched Bionano Laboratories' first OGM-based laboratory developed test (LDT), according to the Sept. 23 press release.
- The company added that Bionano Laboratories recently received CLIA-certification for its lab in San Diego.
- BNGO -3.16% to 3.16% premarket Sept. 23